| Parmax Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540359 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE240T01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -14.81 |
Market Cap(₹Cr) : 13.00 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2.53 | 1.94 | 4.83 | 6.28 | 9.28 | 7.82 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2.53 | 1.94 | 4.83 | 6.28 | 9.28 | 7.82 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.01 | -0.10 | 0.01 | 0.12 | 0.01 |
| Total Income | 2.54 | 1.95 | 4.73 | 6.30 | 9.39 | 7.82 |
| Total Expenditure | 4.12 | 2.19 | 6.46 | 6.18 | 9.08 | 7.30 |
| PBIDT | -1.58 | -0.24 | -1.74 | 0.12 | 0.32 | 0.52 |
| Interest | 0.24 | 0.28 | 0.24 | 0.11 | 0.13 | 0.11 |
| PBDT | -1.82 | -0.52 | -1.97 | 0.01 | 0.19 | 0.41 |
| Depreciation | 0.26 | 0.24 | -0.18 | 0.41 | 0.40 | 0.40 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -0.30 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -2.08 | -0.76 | -1.49 | -0.39 | -0.22 | 0.01 |
| Extra-ordinary Items | 0.00 | 0.00 | -1.07 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -2.08 | -0.76 | -0.42 | -0.39 | -0.22 | 0.01 |
| EPS (Unit Curr.) | -5.56 | -2.04 | -4.00 | -1.05 | -0.58 | 0.03 |
| EPS (Adj) (Unit Curr.) | -5.56 | -2.04 | -4.00 | -1.05 | -0.58 | 0.03 |
| Calculated EPS (Unit Curr.) | -5.56 | -2.04 | -4.00 | -1.05 | -0.58 | 0.03 |
| Calculated EPS (Adj) (Unit Curr.) | -5.56 | -2.04 | -4.00 | -1.05 | -0.58 | 0.03 |
| Calculated EPS (Ann.) (Unit Curr.) | -22.22 | -8.17 | -15.98 | -4.22 | -2.32 | 0.13 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -22.22 | -8.17 | -15.98 | -4.22 | -2.32 | 0.13 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -62.45 | -12.37 | -36.02 | 1.91 | 3.45 | 6.65 |
| PBDTM(%) | -71.94 | -26.80 | -40.79 | 0.16 | 2.05 | 5.24 |
| PATM(%) | -82.21 | -39.18 | -30.85 | -6.21 | -2.37 | 0.13 |